On­ly a third of em­ploy­ers and health plans cov­er GLP-1 drugs for weight loss, re­port says

(This sto­ry is from our new Health Tech newslet­ter. If you’d like to sign up, just click here.)

Com­pa­nies still aren’ …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.